Truvestments Capital’s Olema Pharmaceuticals OLMA Stock Holding History

Truvestments Capital’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.5K	Hold	838	–	–	﹤0.01%	787
2026 Q1	$12.5K	Hold	838	–	–	﹤0.01%	721
2025 Q4	$20.9K	Hold	838	–	–	﹤0.01%	585
2025 Q3	$8.2K	Hold	838	–	–	﹤0.01%	745
2025 Q2	$3.57K	Hold	838	–	–	﹤0.01%	779
2025 Q1	$3.15K	Hold	838	–	–	﹤0.01%	810
2024 Q4	$4.89K	Hold	838	–	–	﹤0.01%	704
2024 Q3	$10K	Buy	+838	New	+$10.7K	﹤0.01%	582
2024 Q2	–	Sell	-1,323	Closed	-$15K	–	534
2024 Q1	$15K	Hold	1,323	–	–	0.01%	462
2023 Q4	$18.6K	Hold	1,323	–	–	0.01%	451
2023 Q3	$16.3K	Hold	1,323	–	–	0.01%	399
2023 Q2	$11.9K	Hold	1,323	–	–	0.01%	437
2023 Q1	$4.59K	Buy	+1,323	New	+$5.4K	﹤0.01%	522

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Truvestments Capital's OLMA Position: Q2 2026 in Review

Truvestments Capital held its Olema Pharmaceuticals (OLMA) position steady in Q2 2026 at 838 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #787.

Truvestments Capital first reported a position in OLMA in Q1 2023 and has held it in 13 quarters since. The position peaked at $20.9K in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Truvestments Capital held 838 shares of Olema Pharmaceuticals worth $10.5K as of Q2 2026.
Truvestments Capital left its Olema Pharmaceuticals share count unchanged in Q2 2026.
Olema Pharmaceuticals made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #787 holding.
Truvestments Capital first reported a position in Olema Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
Truvestments Capital's Olema Pharmaceuticals position peaked at $20.9K in Q4 2025.
185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.